{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:56:47Z","timestamp":1790395007400,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T00:00:00Z","timestamp":1371772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s11096-013-9810-z","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T06:06:27Z","timestamp":1371708387000},"page":"798-804","source":"Crossref","is-referenced-by-count":13,"title":["Blood concentrations of cefuroxime in cardiopulmonary bypass surgery"],"prefix":"10.1007","volume":"35","author":[{"given":"Daphne","family":"Bertholee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G. J.","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel L.","family":"Hijmering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Spanjersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wobbe","family":"Hospes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,21]]},"reference":[{"key":"9810_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.amjsurg.2005.01.015","volume":"189","author":"DW Bratzler","year":"2005","unstructured":"Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Am J Surg. 2005;189:395\u2013404.","journal-title":"Am J Surg"},{"key":"9810_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.athoracsur.2005.06.034","volume":"81","author":"FH Edwards","year":"2006","unstructured":"Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR. The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg. 2006;81:397\u2013404.","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"9810_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMhpr020557","volume":"348","author":"JP Burke","year":"2003","unstructured":"Burke JP. Infection control\u2014a problem for patient safety. N Engl J Med. 2003;348(7):651\u20136.","journal-title":"N Engl J Med"},{"key":"9810_CR4","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1010-7940(01)00991-5","volume":"20","author":"L Ridderstolpe","year":"2001","unstructured":"Ridderstolpe L, Gill H, Granfeldt H, Ahlfeldt H, Rutberg H. Superficial and deep sternal wound complications: incidence, risk factors and mortality. Eur J Cardiothorac Surg. 2001;20:1168\u201375.","journal-title":"Eur J Cardiothorac Surg"},{"key":"9810_CR5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0003-4975(00)02137-8","volume":"71","author":"M Feo De","year":"2001","unstructured":"De Feo M, Renzulli A, Ismeno G, Gregorio R, la Corte A, Utili R, et al. Variables predicting adverse outcome in patients with deep sternal wound infection. Ann Thorac Surg. 2001;71:324\u201331.","journal-title":"Ann Thorac Surg"},{"key":"9810_CR6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1010-7940(02)00084-2","volume":"21","author":"B Gardlund","year":"2002","unstructured":"Gardlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery\u2014microbiology and pathogenesis. Eur J Cardiothorac Surg. 2002;21:825\u201330.","journal-title":"Eur J Cardiothorac Surg"},{"key":"9810_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1010-7940(00)00469-3","volume":"18","author":"I Kriaras","year":"2000","unstructured":"Kriaras I, Michalopoulos A, Turina M, Geroulanos S. Evolution of antimicrobial prophylaxis in cardiovascular surgery. Eur J Cardiothorac Surg. 2000;18:440\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"key":"9810_CR8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","volume":"38","author":"DW Bratzler","year":"2004","unstructured":"Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clin Infect Dis. 2004;38:1706\u201315.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"9810_CR9","first-page":"195","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. AJHP. 2013;70(3):195\u2013283.","journal-title":"AJHP"},{"key":"9810_CR10","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard. Ed 10 document M100\u2013S20; 2010."},{"key":"9810_CR11","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST breakpoint table version 3.1. Availble at http:\/\/www.eucast.org . Last accessed 4 June 2013."},{"key":"9810_CR12","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1177\/0091270008320923","volume":"48","author":"A Viberg","year":"2008","unstructured":"Viberg A, Cars O, Karlsson MO, Jonsson S. Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function. J Clin Pharmacol. 2008;48:1270\u201381.","journal-title":"J Clin Pharmacol"},{"key":"9810_CR13","unstructured":"Flynn Pharma Ltd. Summary of product characteristics cefuroxime; 2009."},{"issue":"2","key":"9810_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00007691-198306000-00001","volume":"5","author":"BR Smith","year":"1983","unstructured":"Smith BR, LeFrock JL. Cefuroxime: Antimicrobial activity, pharmacology, and clinical efficacy. [review]. Ther Drug Monit. 1983;5(2):149\u201360.","journal-title":"Ther Drug Monit"},{"key":"9810_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/AAC.9.5.741","volume":"9","author":"RD Foord","year":"1976","unstructured":"Foord RD. Cefuroxime: human pharmacokinetics. Antimicrob Agents Chemother. 1976;9:741\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9810_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S1807-59322007000300009","volume":"62","author":"JWL Nascimento","year":"2007","unstructured":"Nascimento JWL, Carmona MJC, Strabelli TMV, Auler JOC Jr, Santos SRCJ. Perioperative cefuroxime pharmacokinetics in cardiac surgery. Clinics. 2007;62(3):257\u201360.","journal-title":"Clinics"},{"key":"9810_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1399-6576.2000.440308.x","volume":"44","author":"B Mets","year":"2000","unstructured":"Mets B. The pharmacokinetics of anesthetic drugs and adjuvants during cardiopulmonary bypass. Acta Anaesthesiol Scand. 2000;44:261\u201373.","journal-title":"Acta Anaesthesiol Scand"},{"key":"9810_CR18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1053-0770(97)90108-7","volume":"11","author":"LC Hsu","year":"1997","unstructured":"Hsu LC. Biocompatibility in cardiopulmonary bypass. J Cardiothorac and Vasc Anesth. 1997;11:376\u201382.","journal-title":"J Cardiothorac and Vasc Anesth"},{"issue":"1","key":"9810_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00421-011-1969-1","volume":"112","author":"R Milic","year":"2012","unstructured":"Milic R, Colombini A, Lombardi G, Lanteri P, Banfi G. Estimation of glomerular filtration rate by MDRD equation in athletes: role of body surface area. Eur J Appl Physiol. 2012;112(1):201\u20136.","journal-title":"Eur J Appl Physiol"},{"key":"9810_CR20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semtcvs.2004.01.006","volume":"16","author":"JH Braxton","year":"2004","unstructured":"Braxton JH, Marrin CA, McGrath PD, Morton JR, Norotsky M, Charlesworth DC, et al. 10-year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg. 2004;16:70\u20136.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"9810_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhin.2004.10.004","volume":"59","author":"JWL Nascimento","year":"2005","unstructured":"Nascimento JWL, Carmona MJC, Strabelli TMV, Auler J, Santos SRCJ. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass. J Hosp Infect. 2005;59:299\u2013303.","journal-title":"J Hosp Infect"},{"key":"9810_CR22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0267659107080116","volume":"22","author":"J Mandak","year":"2007","unstructured":"Mandak J, Pojar M, Malakova J, Lonsky V, Palicka V, Zivny P. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass\u2014microdialysis study. Perfusion. 2007;22:129\u201336.","journal-title":"Perfusion"},{"key":"9810_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0924-8579(02)00024-9","volume":"19","author":"P Liu","year":"2002","unstructured":"Liu P, Muller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents. 2002;19:285\u201390.","journal-title":"Int J Antimicrob Agents"},{"key":"9810_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5507\/bp.2008.022","volume":"152","author":"M Pojar","year":"2008","unstructured":"Pojar M, Mandak J, Malakova J, Jokesova I. Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass- microdialysis study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152:139\u201345.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"9810_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/38.1.5","volume":"38","author":"J Mouton","year":"1996","unstructured":"Mouton J, Vinks A. Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations. J Antimicrob Chemother. 1996;38:5\u201315.","journal-title":"J Antimicrob Chemother"},{"key":"9810_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/AAC.40.1.61","volume":"40","author":"DP Nicolau","year":"1996","unstructured":"Nicolau DP, Nightingale CH, Banevicius MA, Fu Q, Quintiliani R. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother. 1996;40:61\u20134.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9810-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9810-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9810-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T22:49:41Z","timestamp":1563230981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9810-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9810"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9810-z","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]}}}